Europe Artificial Blood Market

Europe Artificial Blood Market size was valued at USD 1.2 billion in 2025 and is forecast to grow from USD 1.3 billion in 2026 to reach USD 1.9 billion by 2031, at a CAGR of 9.5%.

Description

The Europe Artificial Blood Market size was valued at USD 1.2 billion in 2025 and is forecast to grow from USD 1.3 billion in 2026 to reach USD 1.9 billion by 2031, at a CAGR of 9.5%. Artificial blood products are oxygen-carrying substitutes engineered to replicate the gas-transport function of natural blood, spanning hemoglobin-based oxygen carriers and perfluorocarbon emulsions designed to deliver critical benefits over allogenic blood transfusions, including extended shelf life, reduced disease-transmission risk, and immediate availability in trauma and battlefield settings without cross-matching requirements. The market sits at the intersection of transfusion medicine, biomaterials engineering, and defense-funded biotechnology innovation, making it one of the most closely watched enabling technologies across the regional emergency-care and military-medicine value chain.

Demand for artificial blood products remains anchored by persistent donor-blood shortages, rising trauma and surgical procedure volumes, and growing defense-sector investment in shelf-stable blood-analog technologies across Germany, the United Kingdom, and France. Beyond trauma and emergency care, artificial blood continues to enable applications in elective surgical procedures, military and battlefield medicine, and rare-blood-type patient management that require immediately available, universally compatible oxygen carriers. Rising healthcare expenditure, expanding clinical-trial activity, and continued advances in hemoglobin-modification and perfluorocarbon-emulsion chemistry are sustaining consumption even as the region works toward broader regulatory approval and clinical adoption beyond current niche applications.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • Europe Artificial Blood Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product Type (Hemoglobin-Based Oxygen Carriers (HBOCs), Perfluorocarbon-Based Oxygen Carriers (PFCs), Others)

      2. By Application (Trauma & Emergency Care, Surgical Procedures, Military & Defense, Others)

      3. By End User (Hospitals & Trauma Centers, Ambulatory Surgical Centers, Military & Defense Organizations, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • Germany Artificial Blood Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product Type

      2. By Application

      3. By End User

  • United Kingdom Artificial Blood Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product Type

      2. By Application

      3. By End User

  • France Artificial Blood Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product Type

      2. By Application

      3. By End User

  • Rest of Europe Artificial Blood Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product Type

      2. By Application

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • Europe Artificial Blood Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Hemarina SA

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. KaloCyte, Inc.

    3. SpheriTech Limited

    4. Hemoglobin Oxygen Therapeutics LLC

    5. NuvOx Pharma LLC

    6. Prolong Pharmaceuticals, LLC

    7. Sangart, Inc.

    8. Vaxxinity Blood Sciences

    9. VirTech Bio, Inc.

    10. Cerus Corporation

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology